Rare diseases, orphan drugs and their regulation: questions and misconceptions

Nature Reviews Drug Discovery 9, 921-929 (December 2010) | doi:10.1038/nrd3275

Erik Tambuyzer

Sustained advocacy efforts driven by patients' organizations to make rare diseases a health priority have led to regulatory and economic incentives for .....